In collaboration with the CRUK Clinical Trials Unit, Glasgow
Short Course Oncology Treatment - A study of adjuvant chemotherapy in colorectal cancer by the CACTUS and OCTO groups.
The primary aim of the trial is to assess the difference in disease-free survival for patients receiving either 12 weeks or 24 weeks of chemotherapy for colorectal cancer.
Closed: Total recruitment: 6144 patients (30 Nov 2013)
Number of active sites: 243 (01 Nov 2013)